Biotech

All Articles

ArsenalBio increases $325M, turns far from past lead asset

.Toolbox Biosciences is moving on up. The cell treatment company has actually added $325 million in ...

Lilly- backed weight management biotech files IPO

.After raising $170 million back in February, metabolic disease-focused BioAge Labs has submitted to...

Aelis' marijuana use drug flunks phase 2b, steering Indivior to re-think $100M option

.Aelis Farma's chances of safeguarding an easy, positive decision on a $100 million alternative sett...

ProKidney halts period 3 trial certainly not required for tissue therapy approval

.ProKidney has actually stopped some of a set of stage 3 trials for its own tissue therapy for kidne...

Vaxcyte surges on 'impressive' 31-valent PCV gain versus Pfizer

.Vaxcyte introduced what experts called "impressive" phase 1/2 data for its 31-valent pneumococcal i...

Recursion's human brain condition test shows little evidence of efficiency

.Recursion has actually discovered by means of a very early exam of its own tech-enabled approach to...

Acepodia, Pfizer click all together for chemistry-based tissue therapy

.Phone it a situation of really good chemistry: Acepodia, a biotech based on Nobel Champion scientif...

Praxis epilepsy drug reduces seizures in stage 2 hearing

.Praxis Preciseness Medicines has scored another midphase gain in epilepsy this year, with its own s...

Three execs resign as Dyne blog posts blended information for DMD applicant

.After running away a professional grip many years back, Dyne Therapeutics has exposed new phase 1/2...

Arrowhead fires off period 3 data in uncommon metabolic health condition in advance of market encounter Ionis

.Arrowhead Pharmaceuticals has shown its own hand ahead of a potential face-off along with Ionis, re...